Valuation: Medpace Holdings, Inc.

Market Cap 16.15B 13.95B 13.1B 11.92B 22.41B 1,544B 22.78B 154B 60.04B 773B 60.62B 59.31B 2,569B P/E 2026 *
32.9x
P/E 2027 * 30.2x
Enterprise Value 15.34B 13.25B 12.45B 11.33B 21.29B 1,467B 21.65B 146B 57.05B 735B 57.61B 56.36B 2,442B EV / Sales 2026 *
5.38x
EV / Sales 2027 * 4.92x
Free-Float
80.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.59%
1 week-2.06%
Current month+0.24%
1 month+9.31%
3 months+39.31%
6 months+35.15%
Current year+3.00%
1 week 571.74
Extreme 571.735
608.18
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
8/11/26 A Sell

Director

-1,140 0.0041%
8/11/26 A Sell

Chief Executive Officer

-17,610 0.0631%
8/7/26 A Fiscal year

Director

8,511 0.0305%
Change 5-day change 1-year change 3-year change Capi.($)
-0.59%-2.06%+26.35%+118.09% 16.15B
-1.78%-1.68%+1.48%+15.31% 48.42B
+0.85%-0.70%+460.88%+563.55% 43.66B
-2.40%-0.23%+8.13%+71.41% 39.51B
-2.01%-0.85%+23.85%+8.73% 38.95B
-0.50%+0.85%+20.60%+49.65% 32.61B
+0.38%-3.23% - - 16.32B
+0.49%+0.92%+4.11%+23.67% 14.16B
-0.43%+4.70%+78.74%+33.31% 13.37B
-2.59%-0.83%-7.22%-37.03% 12.59B
Average -0.86%+0.36%+68.55%+94.08% 27.57B
Weighted average by Cap. -0.99%+0.53%+90.83%+124.70%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.31B 2.1B 3.96B 273B 4.02B 27.12B 10.6B 137B 10.71B 10.47B 454B 3.03B 2.61B 2.46B 2.23B 4.2B 289B 4.27B 28.79B 11.25B 145B 11.36B 11.12B 482B
Net income 503M 434M 408M 371M 697M 48.06B 709M 4.78B 1.87B 24.06B 1.89B 1.85B 79.97B 547M 472M 444M 403M 759M 52.27B 771M 5.2B 2.03B 26.17B 2.05B 2.01B 86.98B
Net Debt -802M -693M -651M -592M -1.11B -76.72B -1.13B -7.63B -2.98B -38.42B -3.01B -2.95B -128B -1.25B -1.08B -1.02B -924M -1.74B -120B -1.77B -11.91B -4.66B -59.96B -4.7B -4.6B -199B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
14/08/26 $578.50 -0.59% 220,619
13/08/26 $581.95 -2.52% 151,061
12/08/26 $596.98 -1.41% 310,387
11/08/26 $605.50 +0.51% 159,911
10/08/26 $602.43 +1.99% 233,638
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
578.50USD
Average target price
581.83USD
Spread / Average Target
+0.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock